- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
SK Biopharmaceuticals
Market Cap: ₩8.6t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩110,600.00
7D
3.4%
1Y
7.2%
L&C BIOLTD
Market Cap: ₩1.2t
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩49,400.00
7D
52.2%
1Y
190.1%
JW Shinyak
Market Cap: ₩80.4b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,518.00
7D
1.1%
1Y
4.2%